Worldwide Cancer Research Menu

Searching for new treatments for skin cancer

  • Researcher: Dr Claudia Wellbrock
  • Institution: The University of Manchester
  • Award Amount: £174,036 for 3 years from January 2012
  • Cancer Type: Skin Cancer
Searching for new treatments for skin cancer
Dr Wellbrock is using her Worldwide Cancer Research grant to investigate new treatments for melanoma skin cancer, the most dangerous type of skin cancer. Melanoma is usually resistant to many of the cancer treatments. Last year a new drug was shown to be highly effective in killing these type of tumours but sadly many patients became resistant to the treatment very quickly, meaning the drug no longer worked but it is still unclear why or how. Dr Wellbrock has discovered a new way this drug resistance may have occurred and is now searching for drugs that could turn this resistance mechanism off. She will test the drugs in a zebrafish model of melanoma which will also allow her to test other treatments at the same time. In the future, new drugs, like those being researched by Dr Wellbrock, could be given alongside other treatments to help kill the melanoma cells and prevent drug resistance.
Showing: All projects

The Research That Is Happening Right Now

Explore current projects to see how far-reaching our research is from a global perspective.

Projects per page: 31020

Our Impact

See the difference our research projects make.

Our philosophy is very simple: if we believe a project can make a difference in the fight against cancer then we will award a grant to make it happen. We’re not interested in national borders or any kind of geographical bias, just the most promising proposals. And that’s the very reason we ask t...
Read more
Life in the Lab
Supporters often ask us what type of projects their donations are funding. What does a typical day in the life of a cancer researcher look like? To answer these questions and give you an insight into the vital work your support helps us to fund, we've put together this short video....
Read more